-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TRRibB0K7NHcuxa+fYGrrcVZnybA2ma6i5JfRc6lFWgV4GP3wg+C+6ajf9Jtqm40 PJs27nzoBRGoZkFVXHFdWw== 0000950123-10-051332.txt : 20100520 0000950123-10-051332.hdr.sgml : 20100520 20100519182559 ACCESSION NUMBER: 0000950123-10-051332 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100517 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100520 DATE AS OF CHANGE: 20100519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mellanox Technologies, Ltd. CENTRAL INDEX KEY: 0001356104 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 980233400 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33299 FILM NUMBER: 10846323 BUSINESS ADDRESS: STREET 1: 350 OAKMEAD PARKWAY, SUITE 100 CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 408-970-3400 MAIL ADDRESS: STREET 1: 350 OAKMEAD PARKWAY, SUITE 100 CITY: SUNNYVALE STATE: CA ZIP: 94085 8-K 1 f55891e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 17, 2010
 
Mellanox Technologies, Ltd.
(Exact name of Registrant as Specified in its Charter)
         
Israel
(State or other jurisdiction
of incorporation)
  001-33299
(Commission
File Number)
  98-0233400
(I.R.S. Employer
Identification No.)
Hermon Building
Yokneam, Israel 20692

(Address of Principal Executive Offices)
+972-4-909-7200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 5.02.   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) Compensatory Arrangements of Certain Officers.
Approval of 2010 Base Salary and Cash Bonus Previously Paid to Eyal Waldman, President and Chief Executive Officer (the “CEO”) of Mellanox Technologies, Ltd. (the “Company”).
Further to the approval of the Company’s Audit Committee (the “Committee”) and its Board of the Directors (the “Board”), at the Company’s 2010 Annual General Meeting of Shareholders held on May 17, 2010 (the “Meeting”), the Company’s shareholders approved the increase in the annual base salary of the CEO from $325,000 to $375,000, effective April 1, 2010, and approved the payment of the cash bonus previously paid to the CEO in the amount of $142,000 for services rendered for the fiscal year ended December 31, 2009.
Approval and Ratification of Equity Awards Previously Granted to CEO.
Further to the approval of the Committee and the Board, at the Meeting the Company’s shareholders ratified and approved the following equity awards previously granted to the Company’s CEO (each, a “Prior Equity Award” and, collectively, the “Prior Equity Awards”):
  (i)   An option to purchase 49,578 ordinary shares at an exercise price per share equal to $18.22, which was previously granted on December 31, 2007 and which vested over fours years, with 1/4 of the shares subject to the option vesting on December 31, 2008 and then at the rate of 1/48 of the original number of shares subject to the option monthly thereafter, so long as Mr. Waldman remained an officer or employee. This option grant was subsequently surrendered by Mr. Waldman in exchange for the grant made on April 22, 2009, as described under item (iii) below, and is no longer outstanding.
  (ii)   An option to purchase 90,000 ordinary shares at an exercise price per share equal to $8.23, which was previously granted on December 26, 2008 and which vests over four years, with 1/4 of the shares subject to the option vesting on December 26, 2009 and then at the rate of 1/48 of the original number of shares subject to the option monthly thereafter, so long as Mr. Waldman remains an officer or employee.
  (iii)   An option to purchase 40,972 ordinary shares at an exercise price per share equal to $10.23, which was previously granted on April 22, 2009 in exchange for the surrender by Mr. Waldman of the option described under item (i) above, and which vests over three years, with 1/3 of the shares subject to the option vesting on April 22, 2010 and then in equal installments monthly thereafter, so long as Mr. Waldman remains an officer or employee.
  (iv)   45,000 restricted stock units, which was previously granted on January 5, 2010 and which vests over four years at the rate of 13/48 of the shares on February 1, 2011, and thereafter at the rate of 3/48 of the original number of the shares on the first day of each quarterly period of May, August, November and February commencing May 1, 2011, with the final 2/48 of the original number of shares vesting on January 1, 2014, so long as Mr. Waldman remains an officer or employee.
All of the above Prior Equity Awards were previously granted pursuant to our Global Share Incentive Plan (2006), which plan provides for the grant of equity awards to eligible officers, directors, employees and consultants and which plan was previously approved by shareholders in accordance with the requirements of Israeli law. The per share exercise prices of each of the above Prior Equity Awards was the closing market price per share on the respective dates of grant of such Prior Equity Awards.
Approval and Ratification of All Past Perquisites Paid to CEO and Authorization of Board or Compensation Committee to Approve Perquisites from Time to Time.
Further to the approval of the Committee and the Board, at the Meeting the Company’s shareholders ratified and approved all past perquisites previously paid to the CEO related to the performance of his services as the chief executive officer, president and chairman of the Board, and authorized the Board or the Compensation Committee of

 


 

the Board to approve the extent of such perquisites from time to time. Such perquisites include items such as rent expenses, household expenses, tax reimbursements related to perquisites provided and accommodation expenses.
Approval of Changes to Non-Employee Director Cash Compensation.
Further to the approval of the Committee and the Board, at the Meeting the Company’s shareholders approved the proposed increase to the annual retainer fees paid to the non-employee directors and the elimination of the fees paid to non-employee directors for each Board or committee meeting attended. The revised compensation amounts are as follows: (i) $35,000 per year for service as a Board member; (ii) $25,000 per year for service as chairperson of the Committee and $7,000 per year each for service as chairperson of the Compensation and of the Nominating and Corporate Governance Committees of the Board; (iii) $5,000 per year for service as a member of the Committee and $3,000 per year each for service as a member of the Compensation and of the Nominating and Corporate Governance Committees of the Board; and (iv) no fees to be paid for each Board or committee meeting attended; provided that non-employee directors are reimbursed by the Company for expenses incurred in connection with attending such meetings.
Approval of Changes to Non-Employee Director Option Grant Policy.
Further to the approval of the Committee and the Board, at the Meeting the Company’s shareholders approved the proposed amendments to the initial and annual, automatic, non-discretionary equity awards made to non-employee directors pursuant to our Non-Employee Director Option Grant Policy (the “Policy”), as follows: (i) each new non-employee director will receive an option to purchase 50,000 ordinary shares as of the date he or she first becomes a non-employee director, which will vest in equal monthly installments over three years following their respective dates of grant, provided the director continues to serve as a non-employee director on the Board; and (ii) thereafter, following the date of each annual general meeting, each individual who continues to serve as a non-employee director on such date will receive an award of 5,000 restricted stock units, which will vest in equal monthly installments over the one-year period following the date of grant, provided the director continues to serve as a non-employee director on the Board.
The foregoing description of the Policy, as amended to reflect the actions approved by the Company’s shareholders at the Meeting (as amended, the “Amended Policy”), is qualified in its entirety by reference to the text of the Amended Policy, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 5.07.   Submission of Matters to a Vote of Security Holders.
At the Meeting, the Company’s shareholders voted on the following eleven proposals:
Proposal No. 1: To elect four directors to the Board to serve a one-year term expiring at the 2011 Annual General Meeting of Shareholders:
                                 
Nominee   For   Against   Abstain   Non-votes
Eyal Waldman
    17,851,675       3,921,893       14,529       3,028,613  
Glenda Dorchak
    17,856,537       3,894,523       37,037       3,028,613  
Irwin Federman
    17,856,450       3,894,610       37,037       3,028,613  
Thomas Weatherford
    17,856,908       3,894,602       36,587       3,028,613  
Each of the above nominees was elected.
Proposal No. 2: To elect two outside directors to the Board to each serve a three-year term expiring on May 17, 2013:
                                 
Nominee   For   Against   Abstain   Non-votes
Amal M. Johnson
    17,867,514       3,884,046       36,537       3,028,613  
Thomas J. Riordan
    17,868,346       3,883,125       36,626       3,028,613  

 


 

Each of the above nominees was elected.
Proposal No. 3: To approve the appointment of Eyal Waldman, the Company’s CEO, as chairman of the Board for an additional three-year term.
             
For   Against   Abstain   Non-votes
18,228,237
  6,530,759   57,710   0
Proposal No. 3 was approved.
Proposal No. 4: To approve (i) the increase in annual base salary of Eyal Waldman from $325,000 to $375,000 effective April 1, 2010, and (ii) the cash bonus previously paid to Mr. Waldman in the amount of $142,000 for services rendered for the fiscal year ended December 31, 2009.
             
For   Against   Abstain   Non-votes
24,608,293   151,461   56,952   0
Proposal No. 4 was approved.
Proposal No. 5: To ratify and approve the Prior Equity Awards to the CEO.
             
For   Against   Abstain   Non-votes
13,185,065   8,546,205   56,827   3,028,613
Proposal No. 5 was approved.
Proposal No. 6: To ratify and approve all past perquisites paid to the CEO and to authorize the Board or the Compensation Committee of the Board to approve the extent of such perquisites from time to time.
             
For   Against   Abstain   Non-votes
17,992,344   6,758,175   66,186   0
Proposal No. 6 was approved.

 


 

Proposal No. 7: To approve certain increases to the annual retainer fees paid to non-employee directors and to eliminate the fees paid to non-employee directors for each board or committee meeting attended.
             
For   Against   Abstain   Non-votes
24,600,308   177,536   38,863   0
Proposal No. 7 was approved.
Proposal No. 8: To approve certain changes to the initial and annual, automatic, non-discretionary grants made to non-employee directors pursuant to the Policy.
             
For   Against   Abstain   Non-votes
16,154,903   5,553,769   79,425   3,028,613
Proposal No. 8 was approved.
Proposal No. 9: To approve an amendment to the indemnification undertaking by and among the Company and each of its directors and officers.
             
For   Against   Abstain   Non-votes
18,054,631   6,682,240   79,836   0
Proposal No. 9 was approved.
Proposal No. 10: To ratify and approve the purchase of liability insurance for directors and officers of the Company and its subsidiaries.
             
For   Against   Abstain   Non-votes
24,670,953   109,217   36,538   0
Proposal No. 10 was approved.

 


 

Proposal No. 11: To appoint PricewaterhouseCoopers as independent registered public accounting firm for the fiscal year ended December 31, 2010 and to authorize the Committee to determine our accounting firm’s remuneration in accordance with the volume and nature of their services.
             
For   Against   Abstain   Non-votes
24,756,135   47,062   13,511   0
Proposal No. 11 was approved.
Item 9.01.   Financial Statements and Exhibits.
(d) Exhibits.
         
Exhibit    
Number   Description
  10.1    
Mellanox Technologies, Ltd. Amended and Restated Non-Employee Director Option Grant Policy

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
         
Date: May 18, 2010  MELLANOX TECHNOLOGIES, LTD.
 
 
  By:   /s/ Michael Gray    
    Name:   Michael Gray   
    Title:   Chief Financial Officer   

 


 

         
Exhibit Index
         
  10.1    
Mellanox Technologies, Ltd. Amended and Restated Non-Employee Director Option Grant Policy

 

EX-10.1 2 f55891exv10w1.htm EX-10.1 exv10w1
Exhibit 10.1
MELLANOX TECHNOLOGIES, LTD.
Amended and Restated
Non-Employee Director Option Grant Policy
Amendments Adopted by the Board of Directors: January 26, 2010
Approved by the shareholders of Mellanox Technologies, Ltd.: May 17, 2010
     1. General. This Non-Employee Director Option Grant Policy (the “Policy”) has been adopted by the Board of Directors of Mellanox Technologies, Ltd., a company organized under the laws of Israel (the “Company”) and approved by the shareholders of the Company pursuant to the authority of the Mellanox Technologies, Ltd. Global Share Incentive Plan (2006) (the “Plan”). Capitalized but undefined terms used herein shall have the meanings ascribed to them in the Plan This Policy provides for the grant of automatic, non-discretionary Options to Non-Employee Directors, and specifies the number of Shares subject to such Options and the conditions on which such Options shall be granted, become exercisable and/or payable, and expire, and such other terms and conditions as are set forth in this Policy.
     2. Automatic Option Grants.
          (a) Initial Director Options. During the term of the Plan, a person who first becomes a Non-Employee Director automatically shall be granted an Option to purchase 50,000 Shares (an “Initial Director Option”). The Initial Director Option granted under this Policy shall become vested and exercisable in substantially equal monthly installments over the three-year period commencing on the date of grant.
          (b) Annual Director Options. During the term of the Plan, commencing on the date of the Company’s annual meeting of shareholders held in 2010, each Non-Employee Director automatically shall be granted 5,000 restricted stock units pursuant to the Company’s Global Share Incentive Plan (2006) (the “Plan”) (an “Annual Director Option”), effective as of the date immediately following each annual meeting of shareholders, provided the Non-Employee Director continues his status as a Non-Employee Director as of such date. The Annual Director Option granted under this Policy shall become vested and exercisable in substantially equal monthly installments over the one-year period commencing on the date of grant.
     For the avoidance of doubt, a Non-Employee Director elected for the first time to the Board of Directors at an annual meeting of shareholders shall only be granted an Initial Director Option in connection with such election, and shall not be granted an Annual Director Option on the date following such meeting as well. Members of the Board of Directors who are employees of the Company, any subsidiary thereof or any other affiliate of the Company who subsequently retire from employment with the Company or the applicable employer subsidiary or affiliate and remain on the Board of Directors shall not be granted an Initial Director Option but to the extent they are otherwise eligible, shall be granted, at each annual meeting of shareholders after the Non-Employee Director’s retirement from employment with the Company or the applicable employer subsidiary or affiliate of the Company.
     3. Terms and Conditions. Except as otherwise provided in this Policy, the Options granted to Non-Employee Directors pursuant to this Policy shall be subject to the terms and conditions applicable generally to Options granted under the Plan and to any additional restrictions set forth in an applicable Appendix.
          (a) Options granted pursuant to this Policy to Non-Employee Directors who are subject to U.S. federal income tax shall be Non-Qualified Stock Options (as this term is defined in the Appendix for U.S. Taxpayers) and to Non-Employee Directors who are subject to taxation in Israel shall be Options that qualify in accordance with Section 102 of the Israeli Tax Ordinance, 1961.
          (b) The exercise price per Share subject to each Option granted to a Non-Employee Director pursuant to this Policy shall be equal to at least 100% of the fair market value of a Share on the date of grant of the Option.
          (c) [Intentionally left blank].
          (d) The term of each Option granted to a Non-Employee Director granted pursuant to this Policy shall be 10 years from the date of grant of the Option.
          (e) The vesting of any Options granted under this Policy shall cease effective as of the date a Non-Employee Director ceases to be a member of the Board of Directors for any reason.
          (f) Upon a Non-Employee Director’s cessation of service on the Board of Directors for any reason other than for cause or the Non-Employee Director’s death or disability, an Option granted pursuant to this Policy shall remain exercisable for three months following the date of cessation of service, and upon a Non-Employee Director’s

 


 

cessation of service on the Board of Directors as a result of the Non-Employee’s death or disability, an Option granted pursuant to this Policy shall remain exercisable for 12 months following cessation of service; provided, however, anything to the contrary notwithstanding in the Plan or in this Policy, no Option shall be exercisable after the expiration of the term of the Option.
          (g) Options granted pursuant to this Policy shall automatically vest in full and become exercisable immediately prior to a Change in Control.
          (h) Notwithstanding anything to the contrary herein, all Option grants to “external directors” as defined under the Companies Law, 1999, shall be subject to applicable laws, rules and regulations applying to compensation of “external directors” in effect from time to time.
     4. Capitalization Adjustments. The number of Shares subject to the Options granted pursuant to this Policy shall be subject to the adjustment provisions of Section 11 of the Plan.
     5. Incorporation of the Plan. All applicable terms of the Plan apply to this Policy as if fully set forth herein except to the extent such other provisions are inconsistent with this Policy, and all grants of Option hereunder are subject in all respect to the terms of the Plan.
     6. Written Grant Agreement; Authority. The grant of any Option under this Policy shall be made solely by and subject to the terms set forth in a written agreement in a form to be approved by the Administrator and duly executed by the Non-Employee Director and an officer of the Company designated for such purpose by the Administrator from time to time. The officer(s) so designated by the Administrator shall be authorized to take all actions and execute all documents as necessary or desirable to implement the provisions of this Policy, without further action or authorization from the Administrator.
     7. Policy Subject to Amendment, Modification and Termination. This Policy may be amended, modified or terminated by the Administrator in the future at its sole discretion. No Non-Employee Director shall have any rights hereunder unless and until an Option is actually granted. Without limiting the generality of the foregoing, the Administrator hereby expressly reserves the authority to terminate this Policy during any plan year up and until the election of members of the Board of Directors at a given annual meeting of shareholders.
     8. Effectiveness. This Policy shall become effective on the later of the date the Plan becomes effective and the date the Policy is approved by the shareholders of the Company.

 

-----END PRIVACY-ENHANCED MESSAGE-----